Key Takeaways
- Phospholutions surpassed 1 million acres treated with RhizoSorb® in its second year of commercial sales
- Company reported 700+ trials and five years of on-farm data across 18 U.S. states
- Secured three phosphate manufacturing partners to expand production capacity
- Expanded internationally into Canada, Brazil, and additional global markets
- Strengthened leadership team and board to support next phase of growth
Phospholutions Marks Commercial Milestones Amid Phosphorus Supply Pressures
Phospholutions has announced a year of commercial growth as adoption of its RhizoSorb® fertilizer technology accelerates ahead of the 2026 growing season. The company’s progress comes as phosphorus has been designated a U.S. critical mineral, with supply constraints and price volatility increasing focus on nutrient efficiency.
According to Phospholutions, demand for technologies that improve phosphorus use efficiency has grown as producers navigate input cost pressures and tighter operating budgets. RhizoSorb® is designed to enhance crop access to applied phosphorus, serving as a replacement for conventional phosphorus fertilizer applications.
Hunter Swisher, CEO and Founder of Phospholutions, stated: “This past year marked a step-change for Phospholutions, from proving performance to scaling adoption. We’ve validated RhizoSorb across crops and geographies, strengthened our manufacturing foundation, and expanded market access in the U.S. and internationally. Heading into the 2026 season, our focus is execution at scale by expanding availability through our partners and delivering measurable value for growers, acre by acre.”
3 Comments